Skip to main content
NIH funding notice PAR-13-213

Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01)

Closed on April 26, 2016.

Posted
April 25, 2013
Close date
April 26, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,433,537 in first-year total cost, median $651,741.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BBBP-L (56)]4

Most frequent institutions

  1. UNIV OF NORTH CAROLINA CHAPEL HILL1
  2. UNIVERSITY OF ARIZONA1
  3. UNIVERSITY OF CALIFORNIA AT DAVIS1
  4. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under PAR-13-213 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2016Memory Measures for Clinical Trials in Down syndrome and Fragile X syndrome1R01HD088409-01EDGIN, JAMIE O.UNIVERSITY OF ARIZONA, AZ$651,941ZRG1
2015Behavioral Inflexibility in IDD Outcome Measurement1R01HD082127-01BOYD, BRIAN ANTONIOUNIV OF NORTH CAROLINA CHAPEL HILL, NC$651,540ZRG1
2014A Cognitive Test Battery for Intellectual Disabilities1R01HD076189-01A1HESSL, DAVID RUNIVERSITY OF CALIFORNIA AT DAVIS, CA$671,470ZRG1
2014Change-sensitive Measurement of Emotion Dysregulation in ASD1R01HD079512-01MAZEFSKY, CARLA AUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$458,586ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-13-213: Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) | ScienceDex | ConductScience